Article Data

  • Views 221
  • Dowloads 128

Original Research

Open Access

Advanced primary carcinoma of the Bartholin gland: Report of 18 patients

  • Ö. Balat1,*,
  • C. L. Edwards2
  • L. Delclos3

1Department of Obstetrics and Gynecology, Division l)JGynecologic Oncology, University of Gaziantep, Sahinbey Medial Center, Gaziantep, Turkey

2,Department of Gynecologic Oncology

3 the University of Texas, M.D., Anderson Cancer Center, Houston, Texas, USA

4Department of Radiotherapy , the University r)JTexas, M.D., Anderson Cancer Center, Houston, 1has, USA

DOI: 10.12892/ejgo20010146 Vol.22,Issue 1,January 2001 pp.46-49

Published: 10 January 2001

*Corresponding Author(s): Ö. Balat E-mail:

Abstract

Conservative surgery plus radiotherapy for vulvar cancer has been established as a therapeutic alternative to extensive radical surgery and produces a similar cumulative 5-year survival. We retrospectively analyzed the cases of 18 patients with advanced primary carcinoma of the Bartholin gland treated with wide local excision (WLE) or radical vulvectomy and lymphadenectomy followed by radiotherapy (RT) at the University of Texas M. D. Anderson Cancer Center from January 1978 through December 1990. All patients have been observed for a minimum of 7 months (maximum follow-up, 15 years; median follow-up, 9 years). Of the 18 patients, 7 were treated with wide local excision (WLE) followed by radiation therapy (RT) (Group 1), 9 had radical vulvectomy (RV) followed by RT to the vulvar and inguinal-femoral and pelvic node areas (Group II), and 2 were treated with RT alone after biopsy of the tumor (Group III). The 5-year disease-free survival rates were 86%, 78%, and 50% for groups I, II, and III, respectively, and 83% for the whole group. Of 2 patients treated with RT alone, one lived for 6 years with no evidence of disease, and the other lived for 20 months. The rate of local tumor control was 100% for all three treatment groups. There were no significant differences among the treatment groups in rate of primary tumor control or 5-year disease-free survival rate (p=0.1300). The present study demonstrated WLE followed by RT is the best treatment for advanced primary carcinoma of the Bartholin gland. Less radical surgery plus RT produces good long-term survival and has fewer complications.

Keywords

Bartholin gland carcinoma; Radical vulvectomy; Radiotherapy; Wide local excision

Cite and Share

Ö. Balat,C. L. Edwards,L. Delclos. Advanced primary carcinoma of the Bartholin gland: Report of 18 patients. European Journal of Gynaecological Oncology. 2001. 22(1);46-49.

References

[1] Dodson M. G., O'Leary J. A., Orfei E.: "Primary carcinoma of Bartholin's gland". Obstet. Gynecol., 1978, 51, 26.

[2] W heelock J. B., Goplerud D. R., Dunn L. J., Oates III J. F: "Primary carcinoma of the bartholin gland: A report of ten cases" Obstet. Gynecol., 1984, 63, 820.

[3] Leuchter R. S., Hacker N. F.. Voet R. L.. Berek J. S., Townsend D E., Lagasse L. 0.: "Primary carcinoma of the bartholin gland: A report of 14 cases and review of the literature". Obstet. Gynecol.,1982, 60, 361.

[4] Copeland L. J., Sneige N., Gershenson D. M., McGuffee V. B., Abdul-Karim F., Rutledge F. N.: "Bartholin gland carcinoma" Obstet. Gynecol., 1986, 67, 794.

[5] Morrow C. P., Curtin J. P., Townsend D. E.: "Tumors of the vulva". In: "Synopsis of Gynecologic Oncology", 5th ed., New York, Churchill Livingstone, 1993, 65.

[6] Pao W. M., Perez C. A., Kuske R. R., Sommers G. M., Camel H. M., Galakatos A. E.: "Radiation therapy and conservation surgery for primary and recurrent carcinoma of the vulva: report of 40 patients and a review of the literature". Int. J. Radiat. Oncol. Biol. Phys., 1988, 14, 1123.

[7] Perez C .A., Grigsby P. W., Galakatos A., Swanson R., Camel H M., Kao M. S.: "Radiation therapy in the management of careinoma of the vulva with emphasis on conservation therapy". Cancer, 1993, 71, 3707.

[8] Thomas G. M., Dembo A. J. D., Bryson S. C. P., Osborne R., De Petrillo D.: "Changing concepts in the management of vulvar cancer". Gynecol. Oncol., 1991, 42, 92.

[9] SPSS (Statistical Package for Social Sciences) User's Guide, 2nd ed. New York: SPSG Inc., McGraw-Hill, 1986.

[10] Berkson J., Gage R.: "Calculation of survival rates for cancer". Proc. Mayo Clin., 1950, 25, 270.

[11] Lee E., Desu M. A.: "Computer program for comparing k samples with right-censored data". Computer Programs in Biomedicine, 1972, 2, 315.

[12] Hacker N .F., Eifel P., McGuire W. P., Wilkinson E. J.: "Vulva". In: Hoskins W. J., Perez C. A., Young R. C., eds. "Principles and Practice of Gynecologic Oncology". Philadelphia: JB Lippincott, 1992, 537.

[13] Masterson J. G., Goss A. S.: "Carcinoma of the bartholin gland: A review of the literature and report of a new case in an elderly patient treated by radical operation". Am. J. Obst et. Gynecol., 1955, 69, 1323.

[14] Dusenberg K. E., Carlson J. W., LaPorte R. M., Unger J. A., Goswitz J. J., Roback D. M. et al.: "Radical vulvectomy with postoperative irradiation for vulvar cancer: Therapeutic implications of a central block". Int. J. Radiat. Onco/. Biol. Phys., 1994, 29, 989.

[15] Boronow R. C., Hickman B. T., Reagen M. T., Smith A., Steadhman R. E.: "Combined therapy as an alternative to exenteration for locally advanced vulvo-vaginal cancer. II. Results, complication, and dosimetric and surgical considerations". Am. J. Oncol., 1987, 10, 171.

[16] Fletcher G. H.: "Irradiation of subclinical disease in the draining lympatics". Int. J. Radial. Oncol. Biol. Phys., 1984, 10, 939.

[17] Frischbier H.J., Thomsen K.: "Treatment of cancer of the vulva with high-energy electrons". Am. J. Obstet. Gynecol., 1971, 111, 431.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top